|
2009 Journal Article Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancersHerbertson, Rebecca A., Tebbutt, Niall C., Lee, Fook-Thean, MacFarlane, David J., Chappell, Bridget, Micallef, Noel, Lee, Sze-Ting, Saunder, Timothy, Hopkins, Wendie, Smyth, Fiona E., Wyld, David K., Bellen, John, Sonnichsen, Daryl S., Brechbiel, Martin W., Murone, Carmel and Scott, Andrew M. (2009). Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers. Clinical Cancer Research, 15 (21), 6709-6715. doi: 10.1158/1078-0432.CCR-09-0536 |
|
2009 Journal Article Nesidioblastosis as a cause of focal pancreatic 111In-pentetreotide uptake in a patient with putative VIPoma: another differential diagnosisFrancesconi, Alessandra Bastian, Matos, Marco, Lee, Joseph C., Wyld, David K., Clouston, Andrew D. and Macfarlane, David (2009). Nesidioblastosis as a cause of focal pancreatic 111In-pentetreotide uptake in a patient with putative VIPoma: another differential diagnosis. Annals of Nuclear Medicine, 23 (5), 497-499. doi: 10.1007/s12149-009-0252-6 |
|
2009 Journal Article Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab′ fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trialMacfarlane, David, Socrates, Angelides, Eisenberg, Paul, Larcos, George, Roach, Paul, Gerometta, Michael, Smart, Richard, Tsui, Wendy and Scott, Andrew M. (2009). Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab′ fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trial. European Journal of Nuclear Medicine and Molecular Imaging, 36 (2), 250-259. doi: 10.1007/s00259-008-0934-7 |
|
2006 Journal Article Metastatic paraganglioma with extensive bone marrow involvementMorris, Kirk L., Macfarlane, David, Wyld, David and Kennedy, Glen A. (2006). Metastatic paraganglioma with extensive bone marrow involvement. Asia-Pacific Journal of Clinical Oncology, 2 (4), 193-194. doi: 10.1111/j.1743-7563.2006.00068.x |
|
2006 Journal Article Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab 'Macfarlane, David J., Smart, Richard C., Tsui, Wendy W., Gerometta, Michael, Eisenberg, Paul R. and Scott, Andrew M. (2006). Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab '. European Journal of Nuclear Medicine and Molecular Imaging, 33 (6), 648-656. doi: 10.1007/s00259-005-0025-y |
|
2005 Journal Article Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a Sm-153-EDTMP-based preparative regimenKennedy, G. A., Durrant, S., Butler, J., Morton, J., Western, R., Bartlett, M. L., Allison, R. and MacFarlane, D. J. (2005). Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a Sm-153-EDTMP-based preparative regimen. Leukemia, 19 (5), 879-880. doi: 10.1038/sj.leu.2403698 |
|
2004 Journal Article Therapeutic activation of V alpha 24(+)V beta 11(+) NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunityNieda, M, Okai, M, Tazbirkova, A, Lin, H, Yamaura, A, Ide, K, Abraham, R, Juji, T, Macfarlane, DJ and Nicol, AJ (2004). Therapeutic activation of V alpha 24(+)V beta 11(+) NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood, 103 (2), 383-389. doi: 10.1182/blood-2003-04-1155 |
|
2002 Journal Article Dosimetry and toxicity of Quadramet for bone marrow ablation in multiple myeloma and other haematological malignanciesBartlett, Marissa L, Webb, Myles, Durrant, Simon, Morton, A James, Allison, Roger and Macfarlane, David J (2002). Dosimetry and toxicity of Quadramet for bone marrow ablation in multiple myeloma and other haematological malignancies. European Journal of Nuclear Medicine and Molecular Imaging, 29 (11), 1470-1477. doi: 10.1007/s00259-002-0934-y |
|
2002 Journal Article 153Sm EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignanciesMacfarlane, D. J., Durrant, S., Bartlett, M. L., Allison, R. and Morton, A. J. (2002). 153Sm EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies. Nuclear medicine communications, 23 (11), 1099-1106. doi: 10.1097/00006231-200211000-00010 |
|
2002 Journal Article Sm-153 EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignanciesMacfarlane, DJ, Durrant, S, Bartlett, ML, Allison, R and Morton, AJ (2002). Sm-153 EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies. Nuclear Medicine Communications, 23 (11), 1099-1106. doi: 10.1097/01.mnm.0000040978.43128.ae |
|
2002 Journal Article Estimating uptake in liver and abdominal tumours for radionuclide therapy dosimetryBartlettt, ML and Macfarlane, DJ (2002). Estimating uptake in liver and abdominal tumours for radionuclide therapy dosimetry. Nuclear Medicine Communications, 23 (8), 743-748. doi: 10.1097/00006231-200208000-00007 |
|
2001 Conference Publication Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.Durrant, S., Irving, I., Mollee, P., Morton, A. J., Webb, M. and Macfarlane, D. (2001). Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.. 27th Annual Meeting of the European Group for Blood and Marrow Transplantation, London, United Kingdom: Nature Publishing Group. |
|
2000 Journal Article 'Liver tail' pseudospleen appearance in denatured erythrocyte scintigraphy with computed tomographic and magnetic resonance correlationsBakar, K. A., MacFarlane, D., Fong, W. and McEwan, L. (2000). 'Liver tail' pseudospleen appearance in denatured erythrocyte scintigraphy with computed tomographic and magnetic resonance correlations. Clinical Nuclear Medicine, 25 (9), 740-742. doi: 10.1097/00003072-200009000-00026 |
|
1999 Journal Article Strontium and samarium therapy for bone metastases from prostate carcinomaDickie, Graeme J. and Macfarlane, David (1999). Strontium and samarium therapy for bone metastases from prostate carcinoma. Australasian radiology, 43 (4), 476-479. doi: 10.1046/j.1440-1673.1999.00716.x |
|
1999 Journal Article Strontium and samarium therapy for bone metastases from prostate carcinomaDickie, G. and Macfarlane, D. (1999). Strontium and samarium therapy for bone metastases from prostate carcinoma. Radiation Oncology, 43 (4), 476-479. |
|
1998 Journal Article Iodine-131 anti-B1 antibody for B-cell lymphoma: an update on the Michigan Phase I experienceWahl, R. L., Zasadny, K. R., MacFarlane, D., Francis, I. R., Ross, C. W., Estes, J., Fisher, S., Regan, D., Kroll, S. and Kaminski, M. S. (1998). Iodine-131 anti-B1 antibody for B-cell lymphoma: an update on the Michigan Phase I experience. The Journal of Nuclear Medicine, 39 (8 Suppl), 21S-27S. |
|
1998 Journal Article Prospective evaluation of 2-[F-18]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanomaMacfarlane, DJ, Sondak, V, Johnson, T and Wahl, RL (1998). Prospective evaluation of 2-[F-18]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma. Journal of Clinical Oncology, 16 (5), 1770-1776. |
|
1998 Journal Article Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanomaMacfarlane, D. J., Sondak, V., Johnson, T. and Wahl, R. L. (1998). Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma. Journal of Clinical Oncology, 16 (5), 1770-1776. doi: 10.1200/JCO.1998.16.5.1770 |
|
1998 Conference Publication Iodine-131 anti-B1 antibody for B-cell lymphoma: An update on the Michigan phase I experienceWahl, RL, Zasadny, KR, MacFarlane, D, Francis, IR, Ross, CW, Estes, J, Fisher, S, Regan, D, Kroll, S and Kaminski, MS (1998). Iodine-131 anti-B1 antibody for B-cell lymphoma: An update on the Michigan phase I experience. Symposium on B1 Therapy in Non-Hodgkins Lymphoma - Dosimetry and Clinical Implications, San Antonio Texas, Jun 01, 1997. |
|
1997 Conference Publication Venoconstriction is impaired during volume unloading in chronic heart failureAtherton, J., Thomson, H. L., Macfarlane, D., Fong, W., Moore, T., Wright, K., Muehle, G., Fitzpatrick, L. and Frenneaux, M. (1997). Venoconstriction is impaired during volume unloading in chronic heart failure. 3rd International Congress of Nuclear Cardiology, Florence, Italy, April 1997. Journal of Nuclear Cardiology: Springer. doi: 10.1016/S1071-3581(97)91237-X |
